Ex-Novartis Oncology CEO Liz Barrett has joined UroGen Pharma. Barrett is taking over as CEO of the uro-oncology specialist at a time when it is working on a rolling NDA that could lead to its first drug approval.
Your email address will not be published. Required fields are marked *
Which word is in bold: first, second, third, fourth or fifth? *
Save my name, email, and website in this browser for the next time I comment.
Leave a Comment